drugset / Trial / NCT00576459

Safety and Efficacy of Intravitreal Fluocinolone Acetonide Implants in Patients With Diabetic Macular Edema

NCT00576459

Phase 2 Completed 40 enrolled Bausch & Lomb Incorporated
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a 3-year randomized, dose masked, three-arm controlled, pilot study to evaluate the safety and efficacy of the intravitreal FA implants (0.59mg and 2.1mg), when compared to laser photocoagulation in the treatment of patients with diabetic macular edema.

Timeline

Start
2003-03
Primary completion
2006-06
Completion
2006-07

Drugs

EvaluationDrugModalityDoseRoute
Subject fluocinolone acetonide Small molecule 0.59 mg Intravitreal
Subject fluocinolone acetonide Small molecule 2.1 mg Intravitreal